medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number 4

<< Back Next >>

Med Int Mex 2006; 22 (4)

Influence of the systemic inflammatory response syndrome on the stay days in an ICU of patients with hypertensive illness of pregnancy

Duarte MJ, Díaz MS, Rubio GJ, Vargas GRB, Lee Eng CV, Fernández PLY
Full text How to cite this article

Language: Spanish
References: 17
Page: 272-277
PDF size: 307.57 Kb.


Key words:

systemic inflammatory response syndrome, APACHE II score, days stay, mortality.

ABSTRACT

Objective: To determine the incidence of systemic inflammatory response in patients admitted in an intensive therapy unit with diagnosis of hypertensive illness associated to pregnancy (pre-eclampsia) and their complications (eclampsia and HELLP), as well as the influence of the systemic inflammatory response and the APACHE II score in the days of stay in the unit.
Material and methods: In a retrospective study, at the intensive care unit of a general hospital, the records of the patients admitted to the intensive therapy unit were analyzed in a period from January 1st, 1997 to December 31st, 2003. The presence of the systemic inflammatory response syndrome was determined, the patients also grouped about APACHE II score, and correlated with the days of stay in the unit.
Results: The records of 144 patients who entered to the intensive care unit were analyzed. Of which only 138 were included in the study. They were analyzed and they grouped to the patients as they completed or not approaches for the systemic inflammatory response syndrome and the APACHE II score to their entrance to the intensive care unit. It done APACHE II scores measurements and the days stay in the critical care unit. The mean age of the patients was of 25 years (SD 7), the mean gestational age was of 34 weeks (SD 4.6) and the mean of pregnancies was of 3 (SD 2.1) The resolution of the pregnancy was vaginal via in 13 patients (9%) and for cesarean surgery in 131 patients (91%), the mean of days stay was of 4.44 (SD 7.8). Different complications to those of the hypertension induced by the pregnancy were observed in 30 patients (20.8%). It was proven the presence of systemic inflammatory response syndrome in 37 patients (26%) with mean of day stays of 5.3 against 3.9 of the patients that didn’t develop the syndrome. (p = 0.0000028). The presence of the systemic inflammatory response syndrome caused the necessity for more days of stay in the group of patient with eclampsia (0.0029). Mortality was 2.1%.
Conclusion: The presence of systemic inflammatory response syndrome and the APACHE II score, influences mainly in the days of hospital stay in the patients with eclampsia and HELLP.


REFERENCES

  1. Baskett TF, Sternadel J. Maternal intensive care and near-miss mortality in obstetrics. Br J Obstet Gynaecol 1998;105:981-4.

  2. Kilpatrick SJ, Matthay MA. Obstetric patients requiring critical care. A five-year review. Chest 1992;101:1407-12.

  3. Lapinsky SE, Kruczynski K, Slutsky AS. Critical care in the pregnant patient. Am J Respir Crit Care Med 1995;152:427-55.

  4. Briones GJC, Díaz de León PM. Pre-eclampsia, eclampsia. México: Editorial Distribuidora y Editora Mexicana, 2000;pp:7-16.

  5. Zeerleder S, Zwart B. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003;31:1947-51.

  6. González-Quintero VH. Elevated plasma endothelial microparticles: Preeclampsia versus gestational hypertension. Am J Obstet Gynecol 2004;191:1418-24.

  7. Blaauw J, Graaff R. Abnormal endothelium-dependent microvascular reactivity in recently preeclamptic women. Obstet Gynecol 2005;105:626-32.

  8. Law WR, Valli VE, Conlon BA. Therapeutic potential for transient inhibition of adenosine deaminase in systemic inflammatory response syndrome. Crit Care Med 2003;31:1475-81.

  9. Yegenaga I, Hoste E. Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis 2004:817-24.

  10. Willatts S. Anaesthetic lessons to be learnt from confidential inquiries into maternal death. Acta Anaesthesiol Scand 1997;110:25-6.

  11. Hogberg U, Innala E, Sandstrom A. Maternal mortality in Sweden, 1980- 1988. Obstet Gynecol 1994;84:240-4.

  12. O’Donovan M. Are medical records in their current form a liability? IHRIM 1996;37:8-9.

  13. Rochat RW, Koonin LM, Atrash HK, et al. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol 1988;72:91-7.

  14. Bone RC, Balk RA, Cerra FB, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Chest 1992;101:1644-55.

  15. Levy MM, Fink MP, Marshall JC, et al. For the International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.

  16. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995;273:117-23.

  17. Tang LC, Kwok AC, Wong AY, et al. Critical care in obstetrical patients: an eight-year review. Chin Med J Engl 1997;110:936-41.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2006;22